Palliative Resection of Pancreatic AdenocarcinomaReport as inadecuate

Palliative Resection of Pancreatic Adenocarcinoma - Download this document for free, or read online. Document in PDF available to download.

HPB Surgery - Volume 8 1995, Issue 3, Pages 181-183

University Surgical Unit, F level Centre Block Southampton General Hospital Tremona Road Southampton SO16 6YD, USA

Copyright © 1995 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


A survey was carried out by postal questionnaire of the attitudes of British surgeons to pancreaticresection as palliation for ductal adenocarcinoma of the pancreas. Replies from 24 surgeons related toexperience in over 700 resections. The incidence of estimated residual local disease after resection wasmedian 12.5 percent, range 0–35 percent. Half12 of the surgeons felt that pancreatic resection withresidual macroscopic disease was justified. Only 3 12.5 percent surgeons accepted that palliativeresection in the presence of liver metastases was sometimes justifiable. Further evidence is required ofimproved quality of life after resection before the majority of surgeons will accept palliative resectionin the management of pancreatic ductal adenocarcinoma.

Author: C. D. Johnson



Related documents